FDA guidance
Chlorpheniramine Polistirex; Hydrocodone Polistirex (Capsule, Extended Release - Oral)
FDA guidance · Draft · issued Dec 20, 2008
Key facts
| Title | Chlorpheniramine Polistirex; Hydrocodone Polistirex (Capsule, Extended Release - Oral) |
|---|---|
| Status | Draft |
| Issue date | Dec 20, 2008 |
| Center | Center for Drug Evaluation and Research |
| Regulated product | Drugs |
| Topics | Product-Specific Guidance |
At a glance
- None Product codes referenced
- None Recognized standards referenced
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA guidance documents
FDA guidance documents describe the agency's current thinking on regulatory topics. Drafts are issued for comment before a final version is published.
Source: U.S. Food and Drug Administration (FDA), Guidance Documents